MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels
暂无分享,去创建一个
Stefan Holdenrieder | Volker Jung | Frank Becker | V. Jung | J. Ellinger | S. Müller | A. von Ruecker | S. Holdenrieder | Stefan C. Müller | Jörg Ellinger | E. Herrmann | F. Becker | Lena M. Wulfken | Rudolf Moritz | Carsten Ohlmann | Edwin Herrmann | Gisela Walgenbach-Brünagel | Alexander von Ruecker | G. Walgenbach-Brünagel | R. Moritz | C. Ohlmann
[1] E. Ng,et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.
[2] George M Yousef,et al. Accurate molecular classification of kidney cancer subtypes using microRNA signature. , 2011, European urology.
[3] Hans Lehrach,et al. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy , 2009, Journal of cellular and molecular medicine.
[4] Lianbo Yu,et al. Detection of microRNA Expression in Human Peripheral Blood Microvesicles , 2008, PloS one.
[5] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[6] Jean-Jacques Patard,et al. EAU guidelines on renal cell carcinoma: the 2010 update. , 2010, European urology.
[7] A. Harris,et al. Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.
[8] Muneesh Tewari,et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). , 2010, Methods.
[9] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[10] J. Ellinger,et al. Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer. , 2008, The Journal of urology.
[11] M. Seto,et al. Genome‐wide microRNA expression profiling in renal cell carcinoma: significant down‐regulation of miR‐141 and miR‐200c , 2008, The Journal of pathology.
[12] George M Yousef,et al. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. , 2010, Clinical biochemistry.
[13] Bin Tean Teh,et al. MicroRNA profiling of human kidney cancer subtypes. , 2009, International journal of oncology.
[14] T. Leung,et al. Detection and characterization of placental microRNAs in maternal plasma. , 2008, Clinical chemistry.
[15] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[16] G. Bhanot,et al. Identification of a microRNA panel for clear-cell kidney cancer. , 2010, Urology.
[17] Ronald Simon,et al. Bladder Cancer-associated Protein, a Potential Prognostic Biomarker in Human Bladder Cancer* , 2009, Molecular & Cellular Proteomics.
[18] P. Albers,et al. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer. , 2009, The Journal of urology.
[19] D. Ichikawa,et al. Circulating microRNAs in plasma of patients with gastric cancers , 2010, British Journal of Cancer.
[20] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[21] Holger Sültmann,et al. Circulating miRNAs are correlated with tumor progression in prostate cancer , 2011, International journal of cancer.
[22] J. Ellinger,et al. Circulating microRNAs (miRNA) in serum of patients with prostate cancer. , 2011, Urology.
[23] Michael J Kerin,et al. Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer , 2010, Annals of surgery.
[24] Jörg Grigull,et al. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. , 2011, The Journal of urology.
[25] Norbert Gretz,et al. miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.
[26] R. Büttner,et al. CpG Island hypermethylation in cell‐free serum DNA identifies patients with localized prostate cancer , 2008, The Prostate.
[27] Hansjuerg Alder,et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. , 2009, Gynecologic oncology.
[28] Zhaohui Huang,et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer , 2010, International journal of cancer.
[29] George A Calin,et al. Micro-RNA profiling in kidney and bladder cancers. , 2007, Urologic oncology.
[30] Y Dai,et al. Microarray analysis of microRNA expression in renal clear cell carcinoma. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[31] Yurong Fu,et al. Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues , 2010, Journal of Cancer Research and Clinical Oncology.
[32] R. Fimmers,et al. Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators , 2008, International journal of cancer.